Jill Stopfer, MS, CGC, is an Adjunct Associate Professor in the School of Health and Rehabilitation Sciences and teaches in the Master of Science in Genetic Counseling program at MGH Institute of Health Professions and is Associate Director of Genetic Counseling at Dana-Farber Cancer Institute.
She is a graduate of the University of Michigan in Ann Arbor, with a master’s degree in Human Genetics and Genetic Counseling. She also received the University of Michigan’s Genetic Counseling Training Program Diane Baker Distinguished Alumnus Award in 2011.
Ms. Stopfer was among the first genetic counselors in the country to focus primarily on oncology, and she helped establish the cancer genetics service at the University of Pennsylvania Cancer Center, where she worked for over 20 years. She works on numerous educational and policy initiatives, counsels individuals and families with hereditary risks of cancer, and works on a number of research projects looking to optimize the way genetic counseling is offered. She has served as an expert consultant on numerous medical advisory boards. Ms. Stopfer is also a frequent presenter on topics related to cancer genetic counseling, and the author of over 60 publications.
- BS, Biology, State University of New York at Binghamton, Binghamton, NY
- MS, Human Genetics, University of Michigan, Ann Arbor, MI
Bradbury AR, Patrick-Miller LJ, Egleston BL, Hall MJ, Domchek SM, Daly MB, Ganschow P, Grana G, Olopade OI, Fetzer D, Brandt A, Chambers R, Clark DF, Forman A, Gaber R, Gulden C, Horte J, Long JM, Lucas T, Madaan S, Mattie K, McKenna D, Montgomery S, Nielsen S, Powers J, Rainey K, Rybak C, Savage M, Seelaus C, Stoll J, Stopfer JE, Yao XS. (2018) Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results. J Natl Cancer Inst. Feb 27.
Bradbury AR, Patrick-Miller LJ, Egleston BL, DiGiovanni L, Brower J, Harris D, Stevens EM, Maxwell KN, Kulkarni A, Chavez T, Brandt A, Long JM, Powers J, Stopfer JE, Nathanson KL, Domchek SM (2016) Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genet Med. 2016 Jan;18(1):25-33
Powers J, Stopfer JE. (2014) Risk Assessment, Genetic Counseling, and Clinical Care for Hereditary Breast Cancer. J Obstet Gynecol Neonatal Nurs. May-Jun;43(3):361-73
Domchek SM, Tang JB, Stopfer J, Lilli DR, Hamel N, Tischkowitz M, Monteiro AN, Messick TE, Powers J, Yonker A, Couch FJ, Goldgar DE, Davidson HR, Nathanson KL, Foulkes W, Greenberg RA. (2013) Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer. Cancer Discov. Apr;3(4):399-405
Hughes Halbert C, Stopfer JE, McDonald J, Weathers B, Collier A, Troxel AB, Domchek S. (2011)
Long-Term Reactions to Genetic testing for BRCA1 and BRCA2 Mutations: Does Time Heal Women’s Concerns? J Clin Oncol Oct 11